NEW YORK — Sanguina, a developer of at-home health and wellness testing products, said on Tuesday that it has raised $2.8 million in a Series A financing round.
The round was led by Veritus Holdings and included investors George Hornig of the Seed Lab and Stephen Ippolito of Veritus.
Sanguina said it will use the money to accelerate the expansion of its blood health management digital and at-home-based platforms including new tests for circulation and dehydration.
The Peachtree Corners, Georgia-based company was founded in 2019 with technology from the Georgia Institute of Technology, Emory University, Children's Healthcare of Atlanta, and the US Centers for Disease Control and Prevention.
The company's sole commercialized product is AnemoCheck, a semiquantitative colorimetric assay for determining total hemoglobin and calculated hematocrit in whole blood that received 510(k) clearance from the US Food and Drug Administration in late 2017.